On August 15, ADVI Health’s federal and state policy solution leader, Lindsay Bealor Greenleaf, was featured in Managed Healthcare Executive’s recent article discussing the first negotiated prices announced under the Inflation Reduction Act (IRA).

In the article, “Questions Remain about Whether Negotiated Drug Prices will Save Money,” Lindsay discussed her predictions on whether or not these negotiated prices will ultimately result in savings for Medicare and its beneficiaries. “The prices align with our expectations on list price,” Lindsay said. “Does this align with our estimates on net price? I don’t have a solid answer. We’re trying to judge these prices as best we can with public estimates of net prices.”

Read the full article on Managed Healthcare Executive.